Maria João Catalão Selected Research

Peptidoglycan (Murein)

1/2019

Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria João Catalão Research Topics

Disease

5	Infections 01/2022 - 06/2011
3	Tuberculosis (Tuberculoses) 01/2022 - 01/2019
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 01/2018
1	Coinfection 01/2021
1	HIV Infections (HIV Infection) 01/2021

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 01/2022
1	beta-LactamsIBA 01/2022
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Amino Acids FDA Link 01/2021
1	CystatinsIBA 01/2021
1	Cystatin CIBA 01/2021
1	Peptidoglycan (Murein)IBA 01/2019
1	EnzymesIBA 01/2018
1	GP 4 (GP4)IBA 06/2011

Therapy/Procedure

1	Therapeutics 01/2022